Needham & Company Reiterates a 'Buy' on Aastrom Biosciences (ASTM); 2Q11/Early 3Q11 Review - Cell Therapy in the Sun
Go back to Needham & Company Reiterates a 'Buy' on Aastrom Biosciences (ASTM); 2Q11/Early 3Q11 Review - Cell Therapy in the Sun| AASTROM BIOSCIENCES (NASDAQ: ASTM) | Delayed: 2.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.77 | 52 Week High | $7.00 | |||
| Open | $0.94 | 52 Week Low | $2.55 | |||
| Day High | $2.77 | P/E | N/A | |||
| Day Low | $2.77 | EPS | $-23.68 | |||
| Volume | 46,665 | |||||
